Over the past year, despite warnings to the nation, obesity rates continued to climb in 31 states. A new obesity drug may be made available over the counter to help bring these numbers down.
A low-dose of orlistat, which was sold by the prescription name Xenical, is expected to be approved and made available for sale sometime in 2007.
This new product will be labeled Alli and will include educational materials on managing weight in the package. The cost is estimated to be between $1 – $3 daily.
Orlistat prevents approximately 25% of fat calories from being absorbed. The new Alli should be used in conjunction with a reduced-calorie diet and exercise.